Carcinoembryonic antigen (CEA) is, to date, established as a colorectal cancer (CRC)-related tumor marker, but its unsuitability as a screening and prognostic marker has been demonstrated [7]. This evidence concerns the gene CEACAM5 and colorectal cancer.